Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,151–2,175 of 7,816 matching trials · page 87 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Young Adults With Violent Behavior During Early Psychosis (Aim 2) NCT05756855 adapted behavioral intervention Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 15 | Columbia University OTHER |
2025-09-05 |
|
Study of the Neural Basis of Analogical Reasoning NCT02236832 transcranial magnetic stimulation; MRI imaging; EEG recording; Neur... Runs in: France · 1 site |
NA other |
COMPLETED | 130 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2025-09-04 |
|
Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment NCT03446001 TRx0237 16 mg/day; Control; TRx0237 8 mg/day Runs in: Belgium; Canada; France; Italy; Poland; Spain; United Kin... · 103 sites |
PHASE3 other |
COMPLETED | 598 | TauRx Therapeutics Ltd INDUSTRY |
2025-09-04 |
|
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD) NCT05189210 GV1001 Placebo; GV1001 0.56mg; GV1001 1.12mg Runs in: Finland; France; Italy; Netherlands; Poland; Portugal; Sp... · 35 sites |
PHASE2 other |
COMPLETED | 199 | GemVax & Kael INDUSTRY |
2025-09-04 |
|
Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394 Runs in: Germany · 1 site |
NA other |
RECRUITING | 15 | University Hospital, Essen OTHER |
2025-09-04 |
|
Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia NCT07154485 NS101 IV infusion; Placebo IV Infusion |
PHASE2 other |
NOT_YET_RECRUITING | 15 | Hee-Jin Kim OTHER |
2025-09-04 |
|
Noninvasive Brain Stimulation for Mild Cognitive Impairment NCT03331796 Active rTMS (Bilateral DLPFC); Active rTMS (Bilateral LPC); Placebo... Runs in: United States · 1 site |
NA other |
COMPLETED | 69 | Palo Alto Veterans Institute for Research OTHER |
2025-09-03 |
|
Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases NCT05326750 Gamma tACS (40 Hz) over the superior parietal cortex Runs in: Finland · 1 site |
NA other |
RECRUITING | 200 | Kuopio University Hospital OTHER |
2025-09-03 |
|
Music Therapy and Social Work Telehealth for Older Adult Well-Being NCT06219148 Music Therapy Telehealth; Non-Collaborative Social Work Telehealth;... Runs in: United States · 2 sites |
NA other |
COMPLETED | 20 | Alaine E Hernandez, PhD OTHER |
2025-09-03 |
|
Compensatory and Restorative Rehabilitation Techniques in Stroke NCT06325085 compensatory and restorative rehabilitation techniques; Traditional... Runs in: Pakistan · 1 site |
NA other |
COMPLETED | 36 | Riphah International University OTHER |
2025-09-03 |
|
Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab NCT06741553 Lecanemab 10 mg/kg Runs in: China · 1 site |
NA anti-amyloid-antibody |
RECRUITING | 120 | Second Affiliated Hospital, Zhejiang University, School of Medicine OTHER |
2025-09-03 |
|
Synbiotic Formula (SCV09) in Alzheimer's Disease Patients NCT06948929 SCV09 Runs in: Hong Kong · 1 site |
NA other |
RECRUITING | 30 | Chinese University of Hong Kong OTHER |
2025-09-03 |
|
Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research NCT07152418 Lecanemab 10 mg/kg; Conventional anti-dementia treatment group |
NA anti-amyloid-antibody |
NOT_YET_RECRUITING | 120 | Second Affiliated Hospital, Zhejiang University, School of Medicine OTHER |
2025-09-03 |
|
The Care Ecosystem Consortium Effectiveness Study NCT05669365 Care Ecosystem Runs in: United States · 6 sites |
NA other |
COMPLETED | 1,227 | University of California, San Francisco OTHER |
2025-09-02 |
|
Study in Subjects With Mild-to-Moderate Alzheimer's Dementia NCT05834296 ALZN002 (autologous DCs pulsed with E22W mutant peptide).; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
ACTIVE_NOT_RECRUITING | 30 | Alzamend Neuro, Inc. INDUSTRY |
2025-09-02 |
|
The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation NCT06234930 Audiovisual stimulation VR system Runs in: United States · 2 sites |
NA other |
COMPLETED | 27 | Clarity Health Technologies, Inc INDUSTRY |
2025-09-02 |
|
Improving the Quality of Dementia Care Through Innovative Redesign of the Memory Care Environment NCT04350060 Retro-fitted room with technological enhancements Runs in: United States · 1 site |
NA other |
COMPLETED | 10 | Mayo Clinic OTHER |
2025-08-29 |
|
Repurposing Bromocriptine for Abeta Metabolism in Alzheimer's Disease NCT04413344 Bromocriptine Mesilate; Placebos Runs in: Japan · 8 sites |
PHASE1|PHASE2 other |
COMPLETED | 8 | Kyoto University OTHER |
2025-08-29 |
|
Sound and Music for Mild Cognitive Impairment NCT05064007 A: 40 Hz music; B: 40 Hz sound; C: Preferred music Runs in: United States · 1 site |
NA other |
COMPLETED | 52 | Johns Hopkins University OTHER |
2025-08-29 |
|
Preoperative Frailty and Postoperative Neurocognitive Disorders in Geriatric Patients in Georgia NCT06700291 Surgery Runs in: Georgia · 1 site |
NA other |
RECRUITING | 230 | New Hospitals Georgia OTHER |
2025-08-29 |
|
Anticholinergic Burden - Treatment Optimization NCT03208569 Runs in: Sweden · 1 site |
NA other |
COMPLETED | 663 | Region Skane OTHER |
2025-08-28 |
|
GamePlan4Care: Online Support for Family Caregivers NCT04540198 GamePlan4Care; Resources4Care Runs in: United States · 1 site |
NA other |
COMPLETED | 240 | Baylor Research Institute OTHER |
2025-08-28 |
|
Efficacy and Safety on SOM3355 in Huntington's Disease Chorea NCT05475483 Placebo capsules; SOM3355 200 mg capsules; SOM3355 300 mg capsules Runs in: France; Germany; Italy; Poland; Spain; Switzerland; Unite... · 23 sites |
PHASE2 other |
COMPLETED | 139 | SOM Innovation Biotech SA INDUSTRY |
2025-08-28 |
|
Multicomponent Program for Addressing Cognition in Rural Communities NCT07018830 Behavioral Treatment Runs in: United States · 1 site |
NA other |
COMPLETED | 11 | Pennington Biomedical Research Center OTHER |
2025-08-28 |
|
Using SRT to Improve The Drinking Problem Behavior of Elderly People With Dementia During The Care of Day Care NCT07086261 Spaced Retrieval Training Runs in: Taiwan · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 70 | National Taipei University of Nursing and Health Sciences OTHER |
2025-08-28 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial